Trapeziectomy with LRTI or joint replacement for CMC1 arthritis, a randomised controlled trial
Rasmus D. Thorkildsen & Magne Røkkum
Received 30 Mar 2019, Accepted 13 Jun 2019, Published online: 04 Jul 2019
Download citation  https://doi.org/10.1080/2000656X.2019.1635490 

Select Language​▼
Translator disclaimer
Abstract
We compared an uncemented joint replacement (Elektra) with trapeziectomy (with ligament reconstruction and tendon interposition, LRTI) for the treatment of primary osteoarthritis in the first carpometacarpal joint (CMC1) in a randomised controlled trial. Forty patients were included (20 in each group) and followed for 2 years. The median age in the groups was 64 and 61, respectively, with 14 females in each. At final follow-up, there was no difference in the primary outcome measure (the quick disabilities of the arm, shoulder and hand score, QDASH), but the joint replacement group had significantly better motion and strength during the early rehabilitation period and significantly better range of thumb abduction and extension at the last follow-up. There were more complications in the joint replacement group with revision of prosthetic components in five cases, two of them due to cup loosening. Radiologically, lucency zones were seen around either cup or stem in 15 patients. Most were small, but two cases with major osteolysis resulted in revision. Shortening of the thumb ray was observed after trapeziectomy.

Keywords: Thumb, trapeziometacarpal arthritis, osteoarthritis, total joint replacement, arthroplasty, trapeziectomy